Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: An in vivo microdialysis study
Section snippets
Conflict of interest
The authors declare that there are no conflicts of interest in the publication of the present work.
Acknowledgements
We thank Drs. N. Ogiso, Y. Ohya and K. Yano, Division for Research of Laboratory Animals, Nagoya University for their technical assistance. This study was supported in part by a Grant-in-Aid for Scientific Research (No. 19390062, 21790067) from the JSPS, Research on Risk of Chemical Substances, Health and Labor Science Grants supported by Ministry of Health, Labour and Welfare, the CREST from JST, the MEXT Global-COE Program, Academic Frontier Project for Private Universities; matching fund
References (34)
- et al.
Behavioral characterization of dysbindin-1 deficient sandy mice
Behav. Brain Res.
(2009) - et al.
DTNBP1 genotype influences cognitive decline in schizophrenia
Schizophr. Res.
(2007) - et al.
Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study
Neuropsychologia
(2007) - et al.
Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia
Biochem. Biophys. Res. Commun.
(2008) - et al.
The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis
Biol. Psychiatry
(2008) - et al.
Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin
Biochem. Biophys. Res. Commun.
(2006) - et al.
High dopamine turnover in the brains of Sandy mice
Neurosci. Lett.
(2007) - et al.
The in vivo microdialysis recovery of dopamine is altered independently of basal level by 6-hydroxydopamine lesions to the nucleus accumbens
J. Neurosci. Methods
(1991) Alterations of dopamine and serotonin transmission in schizophrenia
Prog. Brain Res.
(2008)- et al.
Monoamine transporters and psychostimulant drugs
Eur. J. Pharmacol.
(2003)
Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia
Am. J. Hum. Genet.
Genetic variation in DTNBP1 influences general cognitive ability
Hum. Mol. Genet.
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
J. Cell Biol.
Dopamine in schizophrenia: a review and reconceptualization
Am. J. Psychiatry
Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia
Am. J. Psychiatry
Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo
J. Biol. Chem.
Cited by (39)
Niacin mitigates blood–brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: Role of GPR109A receptor
2022, Progress in Neuro-Psychopharmacology and Biological PsychiatryThe effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study
2019, Psychiatry Research - NeuroimagingThe influence of aripiprazole and olanzapine on neurotransmitters level in frontal cortex of prenatally stressed rats
2016, Environmental Toxicology and PharmacologyCitation Excerpt :Schizophrenia is a severe mental disease of complex aetiopathogenesis and it often requires prolonged pharmacotherapy (Konradi and Heckers, 2003). As the prevalence of schizophrenia in the global population is high (about 1%) (Nagai et al., 2010), studies aimed at finding the causes of this disorder are an important aspect of medical development in the 21st century. Animal models of schizophrenia (Ratajczak et al., 2013a) that enable the identification of disease symptoms observed in the clinical presentation are one of the basic tools used in experimental studies.
Schizophrenia susceptibility gene product dysbindin-1 regulates the homeostasis of cyclin D1
2016, Biochimica et Biophysica Acta - Molecular Basis of Disease
- 1
Contributed equally to the work.